Udo Reichl

Cited by

	All	Since 2018
Citations	11422	5648
h-index	62	41
i10-index	214	167

1600

800

400

1200

2004200520062007200820092010201120122013201420152016201720182019202020212022202341 36 91 112 175 233 351 421 459 549 609 783 800 690 788 1015 1065 1508 1018 245

Public access

View all

54 articles

9 articles

available

not available

Based on funding mandates

Co-authors

Yvonne GenzelMax Planck Institute for Dynamics of Complex Technical SystemsVerified email at mpi-magdeburg.mpg.de
Erdmann RappHead of Bio/Process Analytics, Max Planck Institute for Dynamics of Complex Technical SystemsVerified email at mpi-magdeburg.mpg.de
Robert HeyerResearcher Otto-von-Guericke UniversityVerified email at mpi-magdeburg.mpg.de
Thilo MuthHead of eScience Unit, Federal Institute for Materials Research and Testing (BAM)Verified email at bam.de
Sascha Young KupkeMax Planck Institute for Dynamics of Complex Technical Systems, Bioprocess EngineeringVerified email at mpi-magdeburg.mpg.de
Frank Stefan HeldtSensyne Health plcVerified email at sensynehealth.com
Sebastian Aljoscha WahlFriedrich-Alexander-Universität Erlangen-NürnbergVerified email at fau.de
Felipe TapiaVaccine Production, Max Planck Institute for Dynamics of Complex Technical SystemsVerified email at mpi-magdeburg.mpg.de
Pavel Marichal-GallardoMax Planck Institute for Dynamics of Complex Technical SystemsVerified email at mpi-magdeburg.mpg.de
Alexander NikolayMiltenyi BiotecVerified email at miltenyi.com
Andreas SchlüterScientist, CeBiTec, Universität BielefeldVerified email at cebitec.uni-bielefeld.de
Lennart MartensFull Professor of Systems Biology, Ghent University and VIB, Ghent, BelgiumVerified email at UGent.be
Kai SundmacherProfessor of Process Systems Engineering, Max Planck Institute for Dynamics of Complex TechnicalVerified email at mpi-magdeburg.mpg.de
Dominique THEVENINMagdeburg, Chatenay-MalabryVerified email at ovgu.de
Markus RehbergSanofi-Aventis Deutschland GmbHVerified email at mpi-magdeburg.mpg.de
Thomas NollBielefeld University, Faculty of Technology & Center for BiotechnologyVerified email at uni-bielefeld.de
Reza MahourMax Planck Institute for Dynamics of Complex Technical SystemsVerified email at mpi-magdeburg.mpg.de
Gwendal GränicherMedical Student, UNIGE, GenevaVerified email at etu.unige.ch
Steffen KlamtMax Planck Institute for Dynamics of Complex Technical Systems, MagdeburgVerified email at mpi-magdeburg.mpg.de
Achim KienleProfessor für Automatisierungsetchnik/ModellbildungVerified email at ovgu.de

Udo Reichl

Max Planck Institute / Otto von Guericke University Magdeburg, Germany

Verified email at mpi-magdeburg.mpg.de

Cell Culture Vaccines Recomb. Proteins Modelling Microbial Communities


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Metabolic effects of influenza virus infection in cultured animal cells: Intra-and extracellular metabolite profiling JB Ritter, AS Wahl, S Freund, Y Genzel, U Reichl BMC systems biology 4 (1), 1-22, 2010	218	2010
Metagenome and metaproteome analyses of microbial communities in mesophilic biogas-producing anaerobic batch fermentations indicate concerted plant carbohydrate degradation A Hanreich, U Schimpf, M Zakrzewski, A Schlüter, D Benndorf, R Heyer, ... Systematic and applied microbiology 36 (5), 330-338, 2013	198	2013
Structured model of influenza virus replication in MDCK cells Y Sidorenko, U Reichl Biotechnology and bioengineering 88 (1), 1-14, 2004	195	2004
Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture Y Genzel, I Behrendt, S König, H Sann, U Reichl Vaccine 22 (17-18), 2202-2208, 2004	189	2004
Continuous cell lines as a production system for influenza vaccines Y Genzel, U Reichl Expert review of vaccines 8 (12), 1681-1692, 2009	185	2009
Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research JE Huffman, M Pučić-Baković, L Klarić, R Hennig, MHJ Selman, ... Molecular & Cellular Proteomics 13 (6), 1598-1610, 2014	178	2014
Mathematical model of influenza A virus production in large‐scale microcarrier culture L Möhler, D Flockerzi, H Sann, U Reichl Biotechnology and bioengineering 90 (1), 46-58, 2005	163	2005
The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation T Muth, A Behne, R Heyer, F Kohrs, D Benndorf, M Hoffmann, M Lehteva, ... Journal of proteome research 14 (3), 1557-1565, 2015	156	2015
Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity B Kalbfuss, A Knöchlein, T Kröber, U Reichl Biologicals 36 (3), 145-161, 2008	148	2008
Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media Y Genzel, RM Olmer, B Schäfer, U Reichl Vaccine 24 (35-36), 6074-6087, 2006	146	2006
Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells Y Genzel, JB Ritter, S König, R Alt, U Reichl Biotechnology progress 21 (1), 58-69, 2005	133	2005
Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection FS Heldt, SY Kupke, S Dorl, U Reichl, T Frensing Nature communications 6 (1), 8938, 2015	132	2015
Downstream processing of cell culture-derived virus particles MW Wolf, U Reichl Expert review of vaccines 10 (10), 1451-1475, 2011	132	2011
Purification of cell culture‐derived human influenza A virus by size‐exclusion and anion‐exchange chromatography B Kalbfuss, M Wolff, R Morenweiser, U Reichl Biotechnology and Bioengineering 96 (5), 932-944, 2007	132	2007
Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture Y Genzel, M Fischer, U Reichl Vaccine 24 (16), 3261-3272, 2006	119	2006
Simultaneous extraction of several metabolites of energy metabolism and related substances in mammalian cells: optimization using experimental design JB Ritter, Y Genzel, U Reichl Analytical biochemistry 373 (2), 349-369, 2008	117	2008
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production F Tapia, D Vázquez-Ramírez, Y Genzel, U Reichl Applied microbiology and biotechnology 100, 2121-2132, 2016	116	2016
Quantitative analysis of cellular proteome alterations in human influenza A virus‐infected mammalian cell lines D Vester, E Rapp, D Gade, Y Genzel, U Reichl Proteomics 9 (12), 3316-3327, 2009	115	2009
New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation V Lohr, A Rath, Y Genzel, I Jordan, V Sandig, U Reichl Vaccine 27 (36), 4975-4982, 2009	114	2009
N‐glycan analysis by CGE–LIF: Profiling influenza A virus hemagglutinin N‐glycosylation during vaccine production J Schwarzer, E Rapp, U Reichl Electrophoresis 29 (20), 4203-4214, 2008	111	2008

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors